Product Information
TESTOSTERONE CYP 200 MG/ML is a generic product labeled by Hospira Inc., priced at $11.3924 per ML under NDC 00409656201. Its NADAC has been published 524 times since Sep 21, 2016.
FDA first approved this application before 1982. Its Orange Book therapeutic-equivalence code is AO.
Strength
200 mg/mL
Manufacturer
Hospira Inc.NDC
00409656201
Classification
Generic
Dosage Form
INJECTION, SOLUTION
Route
INTRAMUSCULAR
Effective Date
9/23/2026
Active Ingredients
TESTOSTERONE CYPIONATEApproval Type
Generic (ANDA)
FDA Application
ANDA085635FDA Approved
Before 1982
TE Code
AO
On Market Since
8/1/2016
Pharmacological Classes
Price Statistics
The NADAC for TESTOSTERONE CYP 200 MG/ML has been published 524 times since Sep 21, 2016, and over the history we have for it it has declined 39.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $11.3924 per ML |
|---|---|
| All-time high | $18.7551 (Oct 12, 2016) |
| All-time low | $10.5971 (Jul 17, 2024) |
| 52-week high | $12.0169 |
| 52-week low | $11.0289 |
| Median price | $14.6319 |
| Average price | $14.3898 |
| Largest weekly change | +33.3% (Aug 21, 2024) |
| Weeks tracked | 524 |
| Tracking since | Sep 21, 2016 |
Generic Alternatives
The matcher finds 7 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 80% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Hospira Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
testosterone cypionate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Androgen class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of TESTOSTERONE CYP 200 MG/ML?
The current National Average Drug Acquisition Cost (NADAC) for TESTOSTERONE CYP 200 MG/ML, manufactured by Hospira Inc., is $11.3924 per ML (NDC 00409656201), effective Sep 30, 2026.
How has the price of TESTOSTERONE CYP 200 MG/ML changed over time?
Over the history we have for it, the NADAC for TESTOSTERONE CYP 200 MG/ML has declined 39.3%. It has been tracked across 524 weekly CMS publications since Sep 21, 2016.
What are the highest and lowest recorded NADAC prices for TESTOSTERONE CYP 200 MG/ML?
Since Sep 21, 2016, the NADAC for TESTOSTERONE CYP 200 MG/ML has ranged from a low of $10.5971 (Jul 17, 2024) to a high of $18.7551 (Oct 12, 2016), with a median of $14.6319 per ML.
Are there cheaper alternatives to TESTOSTERONE CYP 200 MG/ML?
Yes. 7 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, TESTOSTERONE CYP 2,000 MG/10 ML, is $2.3108 per ML — about 80% below TESTOSTERONE CYP 200 MG/ML.
Who manufactures TESTOSTERONE CYP 200 MG/ML?
TESTOSTERONE CYP 200 MG/ML (NDC 00409656201) is labeled by Hospira Inc., and CMS classifies it as a generic product.